| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2850226 | American Heart Journal | 2011 | 8 Pages |
Abstract
The SOLID-TIMI 52 trial will determine the clinical benefit of direct inhibition of Lp-PLA2 activity with darapladib in patients after an acute coronary syndrome.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michelle L. MD, MPH, Eugene MD, Harvey D. MD, Patrick MD, Ph. Gabriel MD, Judith MD, Aldo P. MD, Christoph MD, Douglas MD, Joel L. PharmD, Greg PhD, Mary Ann MD, Elizabeth MD, Christopher P. MD,